title: [Mechanism of inhibition in left ventricular hypertrophy by captopril treatment in spontaneously hypertensive rats].
abstract: To explore the mechanisms by which angiotensin converting enzyme inhibitor (ACEI) prevents the development of left ventricular hypertrophy (LVH), captopril (Cap 100 mg.kg-1/d was administered orally to male spontaneously hypertensive rats from intrauterine period to 16 weeks of age. Male and age-matched untreated WKY rats and SHR were used as controls. Experiments were performed at 40 weeks of age. SBP, left ventricular weight to body weight ratio (LVW/BW), myocardial hydroxyproline (Hypro) and norepinephrine (NE) were determined. The levels of c-myc and c-fos mRNA in the left ventricle were measured by Northern blot. Early-onset Cap therapy significantly decreased SBP at 16 weeks of age. After discontinuance of treatment for 24 weeks, SBP of SHRcap was still maintained at a level lower than that of untreated SHR. LVW/BW and Hypro in SHR cap were markedly reduced. The expression of myocardial c-myc mRNA (n = 5) was decreased by 72% in SHRcap compared with that in the untreated SHR, but the expression of c-fos mRNA (n = 7) and NE was not different between the untreated SHR, SHRcap and WKY rats. These results indicate that early Cap treatment may permanently prevent the development of hypertension, inhibit myocardial hypertrophy (MH), and interstitial fibrosis. Furthermore, the prevention of MH is associated with a decrease in myocardial c-myc mRNA levels, and the development and regression of MH may be irrelevant to proto-oncogene c-fos expression.
authors.affiliation: Hypertension Division, First Affiliated Hospital, Fujian Medical College, Fuzhou.
authors.forename: S C
authors.initials: SC
authors.lastname: Chen
authors.forename: D G
authors.initials: DG
authors.lastname: Chen
authors.forename: Y D
authors.initials: YD
authors.lastname: Bao
mesh_terms: D000818:Animals; D002216:Captopril / Q000627:therapeutic use*; D015870:Gene Expression; D016762:Genes, fos; D016259:Genes, myc; D006973:Hypertension / Q000235:genetics / Q000517:prevention & control*; D017379:Hypertrophy, Left Ventricular / Q000517:prevention & control*; D008297:Male; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY
chemical_list: D012333:RNA, Messenger; D002216:Captopril